Atorvastatin Calcium
Product Images NDC 67296-1620

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 67296-1620). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Sdistributi19051009520 0001)

Atorvastatin Calcium 40 mg tablet packaging label showing 30 tablets, Rx only. The label includes NDC 67296-1620-3, lot number 30213AX1, and expiration date 09/20. Manufacturer listed as Lannett Company Inc., Philadelphia, PA, distributed by Redpharm Drug, Eden Prairie, MN. Instructions to see package insert for usual adult dosage and storage at controlled room temperature 20-25 C (68-77 F) are visible.*

FDA Label Image

Chemical Structure (Atorvastatin Calcium Tablets 1)

Chemical structure of atorvastatin calcium showing molecular components including phenyl groups, fluorophenyl, hydroxyl groups, calcium ion, and associated water molecules as part of the compound's calcium salt form.*

FDA Label Image

Figure 1 (Atorvastatin Calcium Tablets 2)

A line graph depicting cumulative incidence percentage over a period of 3.5 years comparing Atorvastatin and Placebo. The solid line represents Atorvastatin, and the dashed line represents Placebo, showing Atorvastatin with lower cumulative incidence. The graph includes a hazard ratio (HR) of 0.64 with a confidence interval (0.50-0.83) and a p-value of 0.0005.*

FDA Label Image

Figure 2 (Atorvastatin Calcium Tablets 3)

A line graph showing cumulative hazard (%) over time (years) comparing placebo and atorvastatin. The x-axis represents time to first primary endpoint through four years of follow-up, and the y-axis shows cumulative hazard percentage. The atorvastatin group shows a consistently lower cumulative hazard than the placebo group, with a hazard ratio (HR) of 0.63 (0.48-0.83) and p=0.001.*

FDA Label Image

Figure 3 (Atorvastatin Calcium Tablets 4)

A line graph comparing the percentage of subjects experiencing the first major cardiovascular event over time between two Atorvastatin doses: 10 mg (dashed line) and 80 mg (solid line). The x-axis represents time in years (0 to 5), and the y-axis shows the percentage of subjects experiencing the event (0 to 0.2). A hazard ratio (HR) of 0.78 with confidence interval (0.69-0.89) and a p-value of 0.0002 are displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.